Terms of the early-access list
Draft for review. These terms are awaiting the founder’s review and may change before OVision’s public launch.
Research use only
OVision is a research workspace. It does not provide a patient diagnosis or treatment recommendation, and it must not be used to make a clinical decision about any person.
Joining the list
Joining is free and creates no purchase obligation. It does not guarantee access, a date or a price: we review requests from research teams and will email you if your work is a fit.
Before any study
Before any data is shared or any paid work begins, we agree with your team on the study’s scope, data access and price. Nothing on this site is an offer to carry out a study.
What you send us
Send only what the form asks for, and no patient information. What you send is handled as the privacy notice describes.
Contact
Book a call with the founder.